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INTRODUCTION
Ochrobactrum anthropi, formerly classified as Achromobacter
species or Centers for Disease Control groups Vd, is an aero-
bic, oxidase-producing, non-fermenting, Gram-negative baci-
llus (1). O. anthropi is a ubiquitous organism, which is wide-
ly distributed in the environment and water sources includ-
ing normal saline, antiseptic solutions, dialysis liquids, and
swimming pools (2). The organism may be part of the nor-
mal flora of the large intestine and has been isolated from
various clinical specimens (3). O. anthropi is currently con-
sidered to be an opportunistic pathogen, and most human
diseases reported in the literature are consequences of cen-
tral venous catheter line infections in severely ill or immuno-
compromised patients (3, 4). The pathogen usually displays
resistance to commonly used broad-spectrum antimicrobial
agents, including penicillins and cephalosporins (3).
We report a case of O. anthropi spontaneous bacterial peri-
tonitis in a patient without evident impairment of immune
function other than liver cirrhosis. A review of the literature,
found no case of O. anthropi spontaneous bacterial peritonitis
up to now. 
CASE REPORT
A 62-yr-old man was admitted to our hospital with a 1-
day history of abdominal pain and fever. He was known to
have liver cirrhosis. On physical examination, his blood pres-
sure was 105/68 mmHg, pulse rate was 105 beats per min,
and body temperature was 38.2℃. Abdominal examination
revealed diffuse tenderness on the whole abdomen, dimin-
ished bowel sound, and splenomegaly. Laboratory tests showed
hemoglobin concentration of 12.2 g/dL, leukocyte count of
7,580/ L, platelet count of 233,000/ L, serum creatinine
level of 1.36 mg/dL, serum bilirubin level of 5.0 mg/dL, and
serum albumin level of 2.5 g/dL. The analysis of peritoneal
fluid demonstrated an albumin level of 284 mg/dL and leuko-
cyte count of 350/ L (poly 89%, other 5%). The Child-Pugh
score was 13. Empirical treatment with ceftriaxone (2 g every
24 hr) was started with the presumptive diagnosis of spon-
taneous bacterial peritonitis. Several days later, gram nega-
tive bacilli were growing in the cultures of blood and ascites
processed by the BACTEC 9240 unit (Becton Dickinson,
Sparks, MD, U.S.A.). The patient’s subsequent hospital course
was uneventful except for low-grade fever (≤38℃). On the
8th day of admission, his blood pressure was 66/40 mmHg,
pulse rate was 94 beats per min, and body temperature was
35.2℃. Laboratory tests showed a hemoglobin concentra-
tion of 11.0 g/dL, leukocyte count of 13,670/ L, platelet
count of 232,000/ L, creatinine level of 2.26 mg/dL, ascitic
albumin level of 470 mg/dL, and ascitic leukocyte count of
1,190/ L (poly 46%, other 50%). We tried to perform an
Esophagogastroduodenoscopy (EGD) because of his black
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Spontaneous Bacterial Peritonitis due to Ochrobactrum anthropi
: A Case Report 
We report a case of spontaneous bacterial peritonitis from Ochrobactrum anthropi.
O. anthropi is recognized as an emerging pathogen in immunocompromised patients.
In contrast to most previously described cases, the patient reported here had no
indwelling catheter. To our knowledge, no case of O. anthropi spontaneous bacte-
rial peritonitis has been reported in the medical literature until now.
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and tarry stool, but the patient and his family refused to give
his consent to EGD. At that time, the gram-negative bacil-
lus was identified as O. anthropi by the Gram negative Combo
32 kit (Microscan Workaway-96, Dade Behring, West Sac-
ramento, CA, U.S.A.), and the biochemical profile determined
by the API 20 NE system (BioMerieus, Marcy l’Etoile, France)
also gave unequivocal identification of O. anthropi. The organ-
ism yielded positive results in tests for urea, ornithine, and
esculin hydrolysis and failed to produce hydrogen sulfide in
triple-sugar-iron agar, which is collectively consistent with
O. anthropi. The isolate was in vitro susceptible to amikacin,
gentamicin, tobramycin, imipenem, meropenem, ciproflo-
xacin, levofloxacin, and trimethoprim but resistant to all other
tested ( -lactam antibiotics including ceftriaxone). The anti-
biotic was changed to imipenem (250 mg every 6 hr, Esti-
mated CrCl=40 mL/min). On the 10th day of admission, the
patient died in spite of transfusion and inotropic therapy.
DISCUSSION
O. anthropi is currently considered as an emerging pathogen
in immunocompromised patients, especially in the presence
of indwelling medical devices. Cytotoxic chemotherapy, recent
transplantation, hematologic and non-hematologic malig-
nancies are common underlying conditions (5, 6). The first
case of human infection with O. anthropi, a pancreatic abscess,
was reported in 1980 (7). Since then, most human diseases
reported in the literature were a consequence of indwelling
medical devices, such as central venous catheter, drainage
tubes, and intraperitoneal catheters (3, 4). The ability of the
pathogen to adhere to silicone, similar to that of S. aureus and
S. epidermidis, has been shown by in vitro experiment and may
play a role in catheter-associated infection (6, 8, 9). In addi-
tion to central catheter-related infections, O. anthropi may
cause localized pyogenic infections (10), meningitis (11), and
osteomyelitis of bone flap following the implantation of con-
taminated allograft tissue (12), endophthalmitis after vitre-
ous and cataract surgery (13, 14), and endocarditis (15, 16).
Contaminated fluids were the likely source of infection (2).
Five organ transplant recipients developed O. anthropi bac-
teremia after infusion of contaminated antilymphocyte glob-
ulin. The pathogen has also been identified as a causative
agent of peritonitis in patients undergoing continuous ambu-
latory peritoneal dialysis (17). The organism is not unusual
among infants and toddlers without chronic diseases or other
known predisposing factors (3). It has also been recovered
from bile, urine, wounds, stool, throat, and vagina.
Non-fermenting, Gram-negative bacilli that are uncom-
monly isolated may be quite difficult to identify to the species
level. O. anthropi grows readily on MacConkey agar and is
differentiated from Pseudomonas spp. and Flavobacterium by
its absence of pigement production and its peritrichous flag-
ella. A positive oxidase reaction differentiates O. anthropi from
Acinetobacter and Flavomonas. Further segregation of O.
anthropi from other oxidase-positive organisms such as Achro-
mobacter, Alcaligenes and Agrobacterium is based on the produc-
tion of 3-ketolactose and hydrogen sulfide, growth on cetri-
mide and hydrolysis of esculin and urea. Accurate identifi-
cation may require comparison of results obtained by using
several identification systems and may sometimes also require
comparison of those results of conventional tests such as growth
on triple-sugar-iron agar (18).
Our patient in this report, who had underlying disease of
liver cirrhosis as the underlying disease, was suffering from
spontaneous bacterial peritonitis caused by O. anthropi. The
patient had not received intravenous injections for more than
6 months, and we could not find any other predisposing con-
ditions. We speculat that the organism has originated from
the intestinal flora. Enteric bacteria could enter the systemic
circulation from the portal vein by passage through the liver
or by portosystemic shunts in patients with portal hyperten-
sion. Enteric bacteria also may gain access to the peritoneal
cavity by directly traversing the intact intestinal wall. This
observation highlights that O. anthropi should also be con-
sidered a significant pathogen in liver cirrhosis patients.
Typically, O. anthropi isolates are susceptible to commonly
used aminoglycosides, carbapenems, cotrimoxazole, quino-
lones, and sulfonamides; variably susceptible to rifampicin
and tetracyclines; and resistant to beta-lactams (other than
carbapenem), chloramphenicol, macrolides, and trimetho-
prim (1). The strain of the present case showed a matched
susceptibility pattern. In O. anthropi infection, there is a poor
correlation, however, of in vitro susceptibility data with clin-
ical efficacy of antimicrobial therapy. Treatment failure with
imipenem has been reported despite in vitro susceptibility
of the strains (19).
To our knowledge, this case is the first report of sponta-
neous bacterial peritonitis due to O. anthropi. Despite its high
level of resistance to antibiotics, considering that the major-
ity of cases have been described in debilitated host, O. anthropi
has been thought to have low intrinsic pathogenic power and
virulence. However, this case emphasizes that the awareness
of the potential role of O. anthropi in causing spontaneous
bacterial peritonitis is important, given the serious morbid-
ity associated with disseminated O. anthropi infections.
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